These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35173766)

  • 1. Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma.
    Zhu C; Xiao H; Jiang X; Tong R; Guan J
    Front Genet; 2021; 12():819520. PubMed ID: 35173766
    [No Abstract]   [Full Text] [Related]  

  • 2. DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data.
    Zhu C; Tong R; Jiang X; Xiao H; Guan J; Shu J
    Front Genet; 2021; 12():767834. PubMed ID: 35265097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK4 as a Prognostic Marker of Hepatocellular Carcinoma and CDK4 Inhibitors as Potential Therapeutics.
    Lai F; Fang Y; Cheng C; Zhong X; Zheng W; Lan S; Peng Q; Cai X; Cao T; Zhong C; Gao Y
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38231074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDOST Correlated with Malignancies and Immune Microenvironment in Gliomas.
    Chang X; Pan J; Zhao R; Yan T; Wang X; Guo C; Yang Y; Wang G
    Front Immunol; 2022; 13():917014. PubMed ID: 35812432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
    Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
    Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.
    Wen F; Meng F; Li X; Li Q; Liu J; Zhang R; Zhao Y; Zhang Y; Wang X; Ju S; Cui Y; Lu Z
    Front Immunol; 2023; 14():1086342. PubMed ID: 36936971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune landscape of hepatocellular carcinoma: The central role of TP53-inducible glycolysis and apoptosis regulator.
    Qiu L; Ma T; Guo Y; Chen J
    Open Med (Wars); 2024; 19(1):20240999. PubMed ID: 39091612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
    Wang J; Huang R; Huang Y; Chen Y; Chen F
    Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.
    Wei Z; Duan X; Li Q; Li Q; Wang Y
    J Gastrointest Oncol; 2021 Dec; 12(6):2966-2984. PubMed ID: 35070423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immune-related multi-omics analysis of dolichyl-diphosphooligosaccharide protein glycosyltransferase in glioma: Prognostic value exploration and competitive endogenous RNA network identification.
    Liu J; Feng C; Liu M; Zhou Y; Shen Y; Li J; Wei X
    IET Syst Biol; 2023 Oct; 17(5):271-287. PubMed ID: 37606290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.
    Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
    Front Oncol; 2021; 11():665192. PubMed ID: 34123827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of
    Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
    Front Genet; 2022; 13():959832. PubMed ID: 36299588
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma.
    Lin S; Cao Y; Zhu K; Yang C; Zhu X; Zhang H; Zhang R
    J Hepatocell Carcinoma; 2023; 10():1749-1765. PubMed ID: 37841372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma.
    Huang J; Chen X; Zhu W
    Medicine (Baltimore); 2021 Mar; 100(12):e25234. PubMed ID: 33761715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinoma.
    Wu X; Yang SY; Zhang YH; Fang JZ; Wang S; Xu ZW; Zhang XJ
    World J Clin Oncol; 2024 Jan; 15(1):45-61. PubMed ID: 38292659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
    Ma X; Ding Y; Zeng L
    BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
    Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
    World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediator complex subunit 8 is a prognostic biomarker in hepatocellular carcinoma.
    Wu S; Li Q; Cao Y; Luo S; Wang Z; Zhang T
    Am J Transl Res; 2022; 14(3):1765-1777. PubMed ID: 35422940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis.
    Yu T; Lu S; Xie W
    Oncol Lett; 2020 Jul; 20(1):165-172. PubMed ID: 32565944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.